Index
1 Market Overview
1.1 Product Overview and Scope of Fumonisins Immunoaffinity Columns (IAC)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Recovery Rate
1.3.1 Overview: Global Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Recovery Rate: 2018 Versus 2022 Versus 2029
1.3.2 80% Below
1.3.3 80-90%
1.3.4 91-100%
1.3.5 100% Above
1.4 Market Analysis by Application
1.4.1 Overview: Global Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Grains
1.4.3 Feed
1.4.4 Others
1.5 Global Fumonisins Immunoaffinity Columns (IAC) Market Size & Forecast
1.5.1 Global Fumonisins Immunoaffinity Columns (IAC) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Fumonisins Immunoaffinity Columns (IAC) Sales Quantity (2018-2029)
1.5.3 Global Fumonisins Immunoaffinity Columns (IAC) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Gold Standard Diagnostics Horsham
2.1.1 Gold Standard Diagnostics Horsham Details
2.1.2 Gold Standard Diagnostics Horsham Major Business
2.1.3 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.1.4 Gold Standard Diagnostics Horsham Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Gold Standard Diagnostics Horsham Recent Developments/Updates
2.2 LCTech
2.2.1 LCTech Details
2.2.2 LCTech Major Business
2.2.3 LCTech Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.2.4 LCTech Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 LCTech Recent Developments/Updates
2.3 Shimadzu
2.3.1 Shimadzu Details
2.3.2 Shimadzu Major Business
2.3.3 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.3.4 Shimadzu Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shimadzu Recent Developments/Updates
2.4 Biotez Berlin
2.4.1 Biotez Berlin Details
2.4.2 Biotez Berlin Major Business
2.4.3 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.4.4 Biotez Berlin Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Biotez Berlin Recent Developments/Updates
2.5 PerkinElmer
2.5.1 PerkinElmer Details
2.5.2 PerkinElmer Major Business
2.5.3 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.5.4 PerkinElmer Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 PerkinElmer Recent Developments/Updates
2.6 VICAM
2.6.1 VICAM Details
2.6.2 VICAM Major Business
2.6.3 VICAM Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.6.4 VICAM Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 VICAM Recent Developments/Updates
2.7 Ring Biotechnology
2.7.1 Ring Biotechnology Details
2.7.2 Ring Biotechnology Major Business
2.7.3 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.7.4 Ring Biotechnology Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ring Biotechnology Recent Developments/Updates
2.8 R-Biopharm AG
2.8.1 R-Biopharm AG Details
2.8.2 R-Biopharm AG Major Business
2.8.3 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.8.4 R-Biopharm AG Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 R-Biopharm AG Recent Developments/Updates
2.9 CHROMATIFIC
2.9.1 CHROMATIFIC Details
2.9.2 CHROMATIFIC Major Business
2.9.3 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.9.4 CHROMATIFIC Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CHROMATIFIC Recent Developments/Updates
2.10 Neogen
2.10.1 Neogen Details
2.10.2 Neogen Major Business
2.10.3 Neogen Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.10.4 Neogen Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Neogen Recent Developments/Updates
2.11 Shandong Meizheng Bio-Tech
2.11.1 Shandong Meizheng Bio-Tech Details
2.11.2 Shandong Meizheng Bio-Tech Major Business
2.11.3 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.11.4 Shandong Meizheng Bio-Tech Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shandong Meizheng Bio-Tech Recent Developments/Updates
2.12 Pribolab
2.12.1 Pribolab Details
2.12.2 Pribolab Major Business
2.12.3 Pribolab Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.12.4 Pribolab Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Pribolab Recent Developments/Updates
2.13 Jiangsu Suwei Micro-Biology Research
2.13.1 Jiangsu Suwei Micro-Biology Research Details
2.13.2 Jiangsu Suwei Micro-Biology Research Major Business
2.13.3 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.13.4 Jiangsu Suwei Micro-Biology Research Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jiangsu Suwei Micro-Biology Research Recent Developments/Updates
2.14 Shandong Lvdu Bio-Sciences & Technology
2.14.1 Shandong Lvdu Bio-Sciences & Technology Details
2.14.2 Shandong Lvdu Bio-Sciences & Technology Major Business
2.14.3 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.14.4 Shandong Lvdu Bio-Sciences & Technology Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shandong Lvdu Bio-Sciences & Technology Recent Developments/Updates
2.15 Jiangsu Wisdom Engineering & Technology
2.15.1 Jiangsu Wisdom Engineering & Technology Details
2.15.2 Jiangsu Wisdom Engineering & Technology Major Business
2.15.3 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.15.4 Jiangsu Wisdom Engineering & Technology Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Jiangsu Wisdom Engineering & Technology Recent Developments/Updates
2.16 BIOCOMMA
2.16.1 BIOCOMMA Details
2.16.2 BIOCOMMA Major Business
2.16.3 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.16.4 BIOCOMMA Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BIOCOMMA Recent Developments/Updates
2.17 Femdetection
2.17.1 Femdetection Details
2.17.2 Femdetection Major Business
2.17.3 Femdetection Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.17.4 Femdetection Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Femdetection Recent Developments/Updates
2.18 Wuhan Huamei Wisherkon Biotech
2.18.1 Wuhan Huamei Wisherkon Biotech Details
2.18.2 Wuhan Huamei Wisherkon Biotech Major Business
2.18.3 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.18.4 Wuhan Huamei Wisherkon Biotech Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Wuhan Huamei Wisherkon Biotech Recent Developments/Updates
2.19 Changsha Huaxue Biological Technology
2.19.1 Changsha Huaxue Biological Technology Details
2.19.2 Changsha Huaxue Biological Technology Major Business
2.19.3 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.19.4 Changsha Huaxue Biological Technology Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Changsha Huaxue Biological Technology Recent Developments/Updates
2.20 Anavo
2.20.1 Anavo Details
2.20.2 Anavo Major Business
2.20.3 Anavo Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.20.4 Anavo Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Anavo Recent Developments/Updates
2.21 Shandong Vnya Bio-technology
2.21.1 Shandong Vnya Bio-technology Details
2.21.2 Shandong Vnya Bio-technology Major Business
2.21.3 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.21.4 Shandong Vnya Bio-technology Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Shandong Vnya Bio-technology Recent Developments/Updates
2.22 Guanyibio
2.22.1 Guanyibio Details
2.22.2 Guanyibio Major Business
2.22.3 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.22.4 Guanyibio Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Guanyibio Recent Developments/Updates
2.23 Prufunglab
2.23.1 Prufunglab Details
2.23.2 Prufunglab Major Business
2.23.3 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Product and Services
2.23.4 Prufunglab Fumonisins Immunoaffinity Columns (IAC) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Prufunglab Recent Developments/Updates
3 Competitive Environment: Fumonisins Immunoaffinity Columns (IAC) by Manufacturer
3.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Fumonisins Immunoaffinity Columns (IAC) Revenue by Manufacturer (2018-2023)
3.3 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Fumonisins Immunoaffinity Columns (IAC) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Fumonisins Immunoaffinity Columns (IAC) Manufacturer Market Share in 2022
3.4.2 Top 6 Fumonisins Immunoaffinity Columns (IAC) Manufacturer Market Share in 2022
3.5 Fumonisins Immunoaffinity Columns (IAC) Market: Overall Company Footprint Analysis
3.5.1 Fumonisins Immunoaffinity Columns (IAC) Market: Region Footprint
3.5.2 Fumonisins Immunoaffinity Columns (IAC) Market: Company Product Type Footprint
3.5.3 Fumonisins Immunoaffinity Columns (IAC) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Fumonisins Immunoaffinity Columns (IAC) Market Size by Region
4.1.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Region (2018-2029)
4.1.2 Global Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Region (2018-2029)
4.1.3 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Region (2018-2029)
4.2 North America Fumonisins Immunoaffinity Columns (IAC) Consumption Value (2018-2029)
4.3 Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Value (2018-2029)
4.4 Asia-Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Value (2018-2029)
4.5 South America Fumonisins Immunoaffinity Columns (IAC) Consumption Value (2018-2029)
4.6 Middle East and Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Value (2018-2029)
5 Market Segment by Recovery Rate
5.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Recovery Rate (2018-2029)
5.2 Global Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Recovery Rate (2018-2029)
5.3 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Recovery Rate (2018-2029)
6 Market Segment by Application
6.1 Global Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Application (2018-2029)
6.2 Global Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Application (2018-2029)
6.3 Global Fumonisins Immunoaffinity Columns (IAC) Average Price by Application (2018-2029)
7 North America
7.1 North America Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Recovery Rate (2018-2029)
7.2 North America Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Application (2018-2029)
7.3 North America Fumonisins Immunoaffinity Columns (IAC) Market Size by Country
7.3.1 North America Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Country (2018-2029)
7.3.2 North America Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Recovery Rate (2018-2029)
8.2 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Application (2018-2029)
8.3 Europe Fumonisins Immunoaffinity Columns (IAC) Market Size by Country
8.3.1 Europe Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Country (2018-2029)
8.3.2 Europe Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Recovery Rate (2018-2029)
9.2 Asia-Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Fumonisins Immunoaffinity Columns (IAC) Market Size by Region
9.3.1 Asia-Pacific Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Recovery Rate (2018-2029)
10.2 South America Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Application (2018-2029)
10.3 South America Fumonisins Immunoaffinity Columns (IAC) Market Size by Country
10.3.1 South America Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Country (2018-2029)
10.3.2 South America Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Recovery Rate (2018-2029)
11.2 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Market Size by Country
11.3.1 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Fumonisins Immunoaffinity Columns (IAC) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Fumonisins Immunoaffinity Columns (IAC) Market Drivers
12.2 Fumonisins Immunoaffinity Columns (IAC) Market Restraints
12.3 Fumonisins Immunoaffinity Columns (IAC) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Fumonisins Immunoaffinity Columns (IAC) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Fumonisins Immunoaffinity Columns (IAC)
13.3 Fumonisins Immunoaffinity Columns (IAC) Production Process
13.4 Fumonisins Immunoaffinity Columns (IAC) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Fumonisins Immunoaffinity Columns (IAC) Typical Distributors
14.3 Fumonisins Immunoaffinity Columns (IAC) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer